Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system ...

Israeli bombardment killed hundreds of people in Gaza, Palestinian health authorities said on Tuesday (March 18), threatening ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars. Ciara Lee reports. Rome marathon runners pause in silence for Pope ...

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors Financing extends Arbor’s cash runway into 2027 and supports the clinical development of ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.